Epilepsy and paroxysmal conditions

Advanced search


Full Text:


The article provides basic information on the chemical structure, mechanism of action, pharmacokinetics, indications, contraindications, and the prospects of clinical application of new antiepileptic drugs: eslikarbazepin, zonisamide, perampanel and rufinamid. Each newest AEDs has a unique mechanism, improved pharmacokinetics and tolerability, thereby significantly expanding the possibilities of rational therapy of epilepsy.

About the Author

P. N. Vlasov
Moscow State University of Medicine and Dentistry
Russian Federation
Vlasov Pavel Nikolaevich – MD, Professor of Neurology of General Medical Faculty and Neurosurgery, Medical Faculty.Address: ul. Delegatskaya, d. 20-1, Moscow, Russia, 127473. 


1. Belousova E.D. Epilepsiya i paroksizmal'nye sostoyaniya / Epilepsy and paroxysmal conditions. 2014; 1: 27-33.

2. Baulac M., Brodie M.J, Patten A., Segieth J., Giorgi L. Efficacy and tolerability of zonisamide versus controlled release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol. 2012; 11: 579-88.

3. French J.A., Krauss G.L., Wechsler R.T. et al. Poster presented at the 68th Annual Meeting of the American Epilepsy Society, Seattle, Washington, USA, December 5-9, 2014. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy. A randomized trial. Neurology. 2015; 85: 1-8.

4. Glauser T., Ben-Menachem E., Bourgeois B. et al. ILAE Treatment Guidelines: Evidencebased Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes. Epilepsia. 2006; 47: 1094-1120.

5. Glauser T., Ben-Menachem E., Bourgeois B. et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013; 54 (3): 551-563.

6. Krauss G.L., Perucca E., Ben-Menachem E., et al. Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307. Epilepsia. 2014; 55: 1058-1068.


For citations:

Vlasov P.N. PROSPECTS OF APPLICATION OF NEW ANTIEPILEPTIC DRUGS. Epilepsy and paroxysmal conditions. 2015;7(4):40-49. (In Russ.)

Views: 542

ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)